Meridiem Capital Partners LP Elanco Animal Health Inc Transaction History
Meridiem Capital Partners LP
- $1.14 Trillion
- Q4 2024
A detailed history of Meridiem Capital Partners LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Meridiem Capital Partners LP holds 375,516 shares of ELAN stock, worth $4.06 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
375,516Holding current value
$4.06 Million% of portfolio
0.4%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
439Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$899 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$553 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$527 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$252 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$221 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.13B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...